Drugmaker Amgen last week extended its existing 340B contract pharmacy restrictions to federal grantees.

Amgen Extends Contract Pharmacy Restrictions to Grantees, Receives Early Pushback

February 27, 2024 Rich Daly Editor in Chief Views

Biopharmaceutical manufacturer Amgen recently expanded its conditions on 340B pricing at contract pharmacies to include grantees. The Thousand Oaks, California-based [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

Amgen Extends Contract Pharmacy Restrictions to Grantees, Receives Early Pushback

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Rich Daly